DGX vs ELA · P/E 22, rev $5.94B vs P/E 21, rev $155.2M
Quest Diagnostics Incorporated (DGX) versus Envela Corp (ELA) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Envela Corp (ELA) is a luxury goods company listed on US.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported ELA revenue for 2026-06-30 was $155.2M. Net income was $13.0M. Revenue was up 57.7% from 2026-03-31 to 2026-06-30. ELA currently screens at market cap $158.1M and trailing P/E 21.0.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. ELA currently screens at market cap $158.1M and trailing P/E 21.0.
Not investment advice. Open the DGX and ELA stock pages for the full models.
Not investment advice.